Non-alcoholic fatty liver disease: A review with clinical and pathological correlation

被引：26

作者：

Chen, Yen-Ying ^{[1
,2
]}

Yeh, Matthew M. ^{[3
,4
]}

机构：

[1] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan

[2] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan

[3] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA

[4] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA

来源：

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2021年 / 120卷 / 01期

关键词：

Fatty liver; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; GLOBAL EPIDEMIOLOGY; STEATOHEPATITIS; PREVALENCE; FIBROSIS; NAFLD; METAANALYSIS; ASSOCIATION; DIAGNOSIS; STEATOSIS; ALGORITHM;

D O I：

10.1016/j.jfma.2020.07.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in North America and Europe, with increasing prevalence in other regions of the world. Its spectrum encompass steatosis, non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. It is considered as the manifestation of metabolic syndrome in liver, and its development and progression is influenced by complex interaction of environmental and genetic factors. In this review we discuss the histopathological features, differential diagnoses, and the commonly used grading and staging systems of NAFLD. NAFLD associated with other diseases, histological changes after therapeutic intervention and recurrence or occurrence of NAFLD after liver transplantation are also addressed. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.

引用

页码：68 / 77

页数：10

共 50 条

[31] Non-alcoholic fatty Liver disease
Calderaro, Julien
Zafrani, Elie Serge
ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
[32] Non-alcoholic fatty liver disease
Farrell, Geoffrey C.
Wardell, Rebecca
Teoh, Narci
Chitturi, Shiv
INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683
[33] Non-alcoholic fatty liver disease
Adams, LA
Angulo, P
LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
[34] Non-Alcoholic Fatty Liver Disease
Engin, Atilla
OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
[35] Non-alcoholic fatty liver disease
Brent A. Neuschwander-Tetri
BMC Medicine, 15
[36] Non-alcoholic fatty liver disease
Alba, LM
Lindor, K
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
[37] Non-alcoholic fatty liver disease
Sattar, Naveed
Forrest, Ewan
Preiss, David
BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[38] Non-alcoholic fatty liver disease
Li, Wenhao
Alazawi, William
CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
[39] Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis
Sharma, Praveen
Arora, Anil
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
[40] Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Dowman, J. K.
Tomlinson, J. W.
Newsome, P. N.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (05) : 525 - 540

← 1 2 3 4 5 →